Phase 3 study of ivosidenib vs placebo in locally advanced or metastatic IDH1-mutant conventional chondrosarcoma untreated or previously treated with 1 systemic treatment regimen (CHONQUER).

Authors: Andrew J. Wagner, Silvia Stacchiotti, Channa Debruyne, Abdulazeez Salawu, Jean-Yves Blay, Fernando Augusto Batista Campos, Hiroaki Hiraga, Antoine Italiano, Akira Kawai, Ganessan Kichenadasse, Yoshihiro Nishida, Seth Pollack, Zhe Qu, Evinaa Sellaiah, Ilona Tala, Gabriel Tinoco, Jonathan C. Trent, Karina Costa Maia Vianna, Kan Yonemori, William D. Tap

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps11582

Source: Full article

---

Abstract

TPS11582